| abstract |
The present invention provides a preparation for cancer treatment having excellent targeting properties. Aromatase inhibitor, antiandrogen drug, lyase inhibitor, GnRH agonist, GnRH antagonist, angiogenesis inhibitor, tyrosine kinase inhibitor, serine / threonine kinase inhibitor, antibody having anticancer activity, ansamitocin, capecitabine, Sermoleukin, docetaxel hydrate, gemcitabine hydrochloride, oxaliplatin, prednisolone, tegafur / uracil combination drug, dinostatin styramer or sugar chain modified liposome of the present invention containing arsenic trioxide have excellent targeting properties It can be used as a preparation for cancer treatment. |